Skip to main content

Table 5 Tumor recurrence for primary tumor site among NI-RADS categories correlated to the gold standard (old reports and pathology results)

From: Assessment of head and neck-imaging reporting and data system using fluro-deoxy-glucose-positron emission tomography/computerized tomography scan imaging of recurrence of head and neck tumors

 

Mass FDG Uptake

Test value

P-value

Sig

Negative

Positive

No. = 30

No. = 25

NI-RADS

NI-RADS 1

16 (53.3%)

1 (4%)

55.173*

0.001

HS

NI-RADS 2a

5 (16.7%)

0 (0.0%)

NI-RADS 2b

2 (6.7%)

2 (8%)

NI-RADS 3

6 (20%)

12 (48%)

NI-RADS 4

1 (3.3%)

10 (40%)

  1. *Chi-square test